JCOOA_ASCO (@jcooa_asco) 's Twitter Profile
JCOOA_ASCO

@jcooa_asco

Conquering cancer | Open-access journal disseminating high-quality early phase and trial-adjacent studies, to advance care globally. Part of @JCO_ASCO family.

ID: 1935418695557464064

calendar_today18-06-2025 19:26:03

1 Tweet

90 Followers

9 Following

JCOOA_ASCO (@jcooa_asco) 's Twitter Profile Photo

Exciting news for the oncology community! 🎉We're thrilled to launch the official X page for JCO Oncology Advances! Follow us for the latest high-quality, open-access early phase and trial-adjacent research. Let's advance cancer care together.

Exciting news for the oncology community! 🎉We're thrilled to launch the official X page for JCO Oncology Advances! Follow us for the latest high-quality, open-access early phase and trial-adjacent research. Let's advance cancer care together.
Erman Akkus (@erman_akkus) 's Twitter Profile Photo

💉1L biologics in early-onset CRC JCO Oncology Advances 🚨⁉️No benefit of EGFRi in left-sided RAS/RAF wt tumors, in contrast to average-onset 👉ascopubs.org/doi/pdfdirect/… ASCO Dr. Cathy Eng OncoAlert Dr Joseph McCollom DO #cancer #oncology #MedX #colorectal

💉1L biologics in early-onset CRC
<a href="/JCOOA_ASCO/">JCO Oncology Advances</a> 

🚨⁉️No benefit of EGFRi in left-sided RAS/RAF wt tumors, in contrast to average-onset

👉ascopubs.org/doi/pdfdirect/…

<a href="/ASCO/">ASCO</a> <a href="/CathyEngMD/">Dr. Cathy Eng</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/realbowtiedoc/">Dr Joseph McCollom DO</a> #cancer #oncology #MedX #colorectal
JCOOA_ASCO (@jcooa_asco) 's Twitter Profile Photo

👀 New Original Report: Response to Biologics in Patients With Early-Onset Treatment-Naïve Metastatic Colorectal Cancer—An Aide et Recherche en Cancérologie Digestive Database Analysis brnw.ch/21wUdyM #crcsm

JCOOA_ASCO (@jcooa_asco) 's Twitter Profile Photo

With our unique "Trials in Progress" article type, you can publish research from ongoing randomized phase II & III clinical trials (from NCTN & other academic groups) before all the endpoints are met. The perfect way to highlight your work sooner: brnw.ch/21wUl2D

With our unique "Trials in Progress" article type, you can publish research from ongoing randomized phase II &amp; III clinical trials (from NCTN &amp; other academic groups) before all the endpoints are met. 

The perfect way to highlight your work sooner: brnw.ch/21wUl2D